Evie Carchman, MD, FACS

Associate Professor

  • Division of Colorectal Surgery

carchman@surgery.wisc.edu
(608) 262-0422

  • Administrative Assistant: (608) 263-2521

Clinical Science Center
600 Highland Avenue
Madison, WI 53792-7375

Education

  • MD, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA
  • General Surgery Residency, University of Pittsburgh Medical Center, Pittsburgh, PA
  • Colon and Rectal Surgery Fellowship, Cleveland Clinic, Cleveland, OH

Clinical Specialties

Dr. Evie Carchman is a fellowship-trained colon and rectal surgeon. She has special expertise in the treatment of colon cancer, rectal cancer, inflammatory bowel disease, benign conditions of colon, rectum, and anus, and endoscopic treatment of colonic disease. Dr. Carchman utilizes minimally invasive techniques including laparoscopic and single incision laparoscopic surgery for the treatment of colon and rectal disease.

Research Interests

Dr. Carchman’s Research Lab >>

Dr. Carchman’s research interests focus on the pathogenesis and treatment of anal cancer. She has special expertise in the treatment of colon cancer, rectal cancer, inflammatory bowel disease, benign conditions of colon, rectum, and anus, and endoscopic treatment of colonic disease. Dr. Carchman utilizes minimally invasive techniques including laparoscopic and single incision laparoscopic surgery for the treatment of colon and rectal disease.

Recent Publications

  • A phase I study of intra-anal artesunate (suppositories) to treat anal high-grade squamous intraepithelial lesions.
    Fang SH, Plesa M, Carchman EH, Cowell NA, Staudt E, Twaroski KA, Buchwald UK, Trimble CL
    PLoS One 2023; 18(12): e0295647
    [PubMed ID: 38100463]

  • Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review.
    Lozar T, Wang W, Gavrielatou N, Christensen L, Lambert PF, Harari PM, Rimm DL, Burtness B, Grasic Kuhar C, Carchman EH
    Viruses 2023 Nov 25; 15(12)
    [PubMed ID: 38140561]

  • Preclinical Models of Anal Cancer Combined-Modality Therapy.
    Johnson HR, Gunder LC, Gillette A, Sleiman H, Rademacher BL, Meske LM, Culberson WS, Micka JA, Favreau P, Yao E, Matkowskyj KA, Skala MC, Carchman EH
    J Surg Res 2024 Feb; 294: 82-92
    [PubMed ID: 37864962]

  • Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease.
    Gunder LC, Johnson HR, Yao E, Moyer TH, Green HA, Sherer N, Zhang W, Carchman EH
    Viruses 2023 Apr 20; 15(4)
    [PubMed ID: 37112993]

  • Treating acute diverticulitis in pre- and post-solid-organ transplant patients: a single-institution cohort study.
    Klos CL, Bath NM, Carchman E, Leverson G, Lawson E, Sanger CB, King R, Heise C
    Colorectal Dis 2023 Jun; 25(6): 1238-1247
    [PubMed ID: 36945080]

All Publications on PubMed